Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
AssigneeSami Labs Limited
InventorsMuhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
Life of this patent
Estimating the term…
Abstract
Disclosed herein is (i) a method related to the growth promotional activity of plant based fibers on Bacillus coagulans MTCC 5856; (ii) the combination of plant based fibers and Bacillus coagulans MTCC 5856 to inhibit Gram Negative pathogenic bacteria; and (iii) the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based fibers.
Claims9
A method comprising co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers.
A method of inhibiting pathogenic Gram Negative bacteria, comprising:
- obtaining a composition that was produced by co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos mucifera (Coconut) fibers, Zingiber officinale (Ginger) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers;
- and
- contacting the pathogenic Gram Negative bacteria with the obtained composition to inhibit the pathogenic Gram Negative bacteria.
A method for treatment and/or prophylaxis of diet-induced obesity and/or insulin resistance, comprising:
- obtaining a composition that was produced by co-culturing Bacillus coagulans MTCC 5856 with plant fibers selected from the group consisting of Trigonella foenum-graecum (fenugreek) seed fibers, Lycium barbarum seed fibers, Linum usitatissimum (Flax) seed fibers, Cocos nucifera (Coconut) fibers, Zingiber officinale (Ginaer) rhizome fibers, Emblica officinalis (Amla) fruit fibers, Plantago ovata (Psyllium) fibers, and Vaccinium oxycoccos (Cranberry) seed fibers;
- and
- administering an effective amount of the obtained composition to a subject in need of treatment and/or prophylaxis of diet-induced obesity and/or insulin resistance.
Dependencies are inferred from the claim text.